Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge

Vaccine

Volumn 29, Issue 17, 2011, Pages 3106-3110

  Rajasekaran, Parthiban ^a   Surendran, Naveen ^c   Seleem, Mohamed N ^b   Sriranganathan, Nammalwar ^a   Schurig, Gerhardt G ^a   Boyle, Stephen M ^a  

^a CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic resistance; Brucella abortus RB51leuB; Brucella suis; L7 L12 ribosomal protein; SOD; Vaccine; WboA

Indexed keywords

BRUCELLA VACCINE; COPPER ZINC SUPEROXIDE DISMUTASE; GLYCOSYLTRANSFERASE; LEUCINE; RECOMBINANT VACCINE; RIBOSOMAL PROTEIN L7 L12; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUXOTROPHY; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BRUCELLA ABORTUS; BRUCELLA ABORTUS RB51; BRUCELLA SUIS; BRUCELLOSIS; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GENE OVEREXPRESSION; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SWINE DISEASE; TREATMENT OUTCOME; VACCINATION;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL LOAD; BRUCELLA ABORTUS; BRUCELLA SUIS; BRUCELLA VACCINE; BRUCELLOSIS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GLUCOSYLTRANSFERASES; LEUCINE; MICE; MICE, INBRED BALB C; RIBOSOMAL PROTEINS; SPLEEN; SUPEROXIDE DISMUTASE; VACCINES, ATTENUATED;

EID: 79954608293     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.054     Document Type: Article

References (32)

1. Stoffregen W.C., Olsen S.C., Jack Wheeler C., Bricker B.J., Palmer M.V., Jensen A.E., et al. Diagnostic characterization of a feral swine herd enzootically infected with Brucella. J Vet Diagn Invest 2007, 19(May (3)):227-237.
2. Brucella suis infection associated with feral swine hunting - three states, 2007-2008. MMWR Morb Mortal Wkly Rep 2009, 58(June (22)):618-621.
3. Meng X.J., Lindsay D.S., Sriranganathan N. Wild boars as sources for infectious diseases in livestock and humans. Philos Trans R Soc Lond B Biol Sci 2009, 364(September (1530)):2697-2707.
4. Wyckoff A.C., Henke S.E., Campbell T.A., Hewitt D.G., VerCauteren K.C. Feral swine contact with domestic swine: a serologic survey and assessment of potential for disease transmission. J Wildl Dis 2009, 45(April (2)):422-429.
5. Olsen S.C. Brucellosis in the United States: role and significance of wildlife reservoirs. Vaccine 2010, 28(October (5)):F73-F76.
6. Mao K.R., Ding J.B., Cheng J.S., Jiang Y.W., Yao W.S. Construction and characterization of a Brucella suis S2 strain with a chloramphenicol resistance marker. Wei Sheng Wu Xue Bao 2007, 47(6):978-981.
7. Stevens M.G., Hennager S.G., Olsen S.C., Cheville N.F. Serologic responses in diagnostic tests for brucellosis in cattle vaccinated with Brucella abortus 19 or RB51. J Clin Microbiol 1994, 32(April (4)):1065-1066.
8. Guidance for human somatic cell therapy and gene therapy. Hum Gene Ther 2001, 12(February (3)):303-314.
9. Schurig G.G., Sriranganathan N., Corbel M.J. Brucellosis vaccines: past, present and future. Vet Microbiol 2002, 90(December (1-4)):479-496.
10. Stoffregen W.C., Olsen S.C., Bricker B.J. Parenteral vaccination of domestic pigs with Brucella abortus strain RB51. Am J Vet Res 2006, 67(October (10)):1802-1808.
11. Lord V.R., Cherwonogrodzky J.W., Schurig G.G., Lord R.D., Marcano M.J., Melendez G.E. Venezuelan field trials of vaccines against brucellosis in swine. Am J Vet Res 1998, 59(May (5)):546-551.
12. Vemulapalli R., Contreras A., Sanakkayala N., Sriranganathan N., Boyle S.M., Schurig G.G. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice. Vet Microbiol 2004, 102(September (3-4)):237-245.
13. Vemulapalli R., He Y., Buccolo L.S., Boyle S.M., Sriranganathan N., Schurig G.G. Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation. Infect Immun 2000, 68(July (7)):3927-3932.
14. Vemulapalli R., He Y., Cravero S., Sriranganathan N., Boyle S.M., Schurig G.G. Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Infect Immun 2000, 68(June (6)):3286-3289.
15. Oliveira S.C., Zhu Y., Splitter G.A. Recombinant L7/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells. Immunology 1994, 83(December (4)):659-664.
16. Luo D., Ni B., Li P., Shi W., Zhang S., Han Y., et al. Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice. Infect Immun 2006, 74(May (5)):2734-2741.
17. Mallick A.I., Singha H., Chaudhuri P., Nadeem A., Khan S.A., Dar K.A., et al. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection. Vaccine 2007, 25(May (18)):3692-3704.
18. Rajasekaran P., Seleem M.N., Contreras A., Purwantini E., Schurig G.G., Sriranganathan N., et al. Brucella abortus strain RB51 leucine auxotroph as an environmentally safe vaccine for plasmid maintenance and antigen overexpression. Appl Environ Microbiol 2008, 74(November (22)):7051-7055.
19. Yu D.H., Hu X.D., Cai H. A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses. DNA Cell Biol 2007, 26(June (6)):435-443.
20. McQuiston J.R., Schurig G.G., Sriranganathan N., Boyle S.M. Transformation of Brucella species with suicide and broad host-range plasmids. Methods Mol Biol 1995, 47:143-148.
21. Plommet M. Minimal requirements for growth of Brucella suis and other Brucella species. Zentralbl Bakteriol 1991, 275(October (4)):436-450.
22. Bandara A.B., Contreras A., Contreras-Rodriguez A., Martins A.M., Dobrean V., Poff-Reichow S., et al. Brucella suis urease encoded by ure1 but not ure2 is necessary for intestinal infection of BALB/c mice. BMC Microbiol 2007, 7:57.
23. Zwerdling A., Delpino M.V., Barrionuevo P., Cassataro J., Pasquevich K.A., Garcia Samartino C., et al. Brucella lipoproteins mimic dendritic cell maturation induced by Brucella abortus. Microbes Infect 2008, 10(October (12-13)):1346-1354.
24. Oka T., Aoyama Y., Natori Y., Katano T., Endo Y. An efficient expression system for a variant form of the cytotoxic protein alpha-sarcin in Escherichia coli. Biochim Biophys Acta 1992, 1130(March (2)):182-188.
25. Retallack D.M., Schneider J.C., Mitchell J., Chew L., Liu H. Transport of heterologous proteins to the periplasmic space of Pseudomonas fluorescens using a variety of native signal sequences. Biotechnol Lett 2007, 29(October (10)):1483-1491.
26. Forestier C., Moreno E., Meresse S., Phalipon A., Olive D., Sansonetti P., et al. Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes. Infect Immun 1999, 67(August (8)):4048-4054.
27. Billard E., Cazevieille C., Dornand J., Gross A. High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis. Infect Immun 2005, 73(December (12)):8418-8424.
28. Bandara A.B., Poff-Reichow S.A., Nikolich M., Hoover D.L., Sriranganathan N., Schurig G.G., et al. Simultaneous expression of homologous and heterologous antigens in rough, attenuated Brucella melitensis. Microbes Infect 2009, 11(March (3)):424-428.
29. Ramamoorthy S., Sanakkayala N., Vemulapalli R., Duncan R.B., Lindsay D.S., Schurig G.S., et al. Prevention of lethal experimental infection of C57BL/6 mice by vaccination with Brucella abortus strain RB51 expressing Neospora caninum antigens. Int J Parasitol 2007, 37(November (13)):1531-1538.
30. Vemulapalli R., He Y., Boyle S.M., Sriranganathan N., Schurig G.G. Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses. Infect Immun 2000, 68(June (6)):3290-3296.
31. Vemulapalli R., Cravero S., Calvert C.L., Toth T.E., Sriranganathan N., Boyle S.M., et al. Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus. Clin Diagn Lab Immunol 2000, 7(January (1)):114-118.
32. Vemulapalli R., He Y., Sriranganathan N., Boyle S.M., Schurig G.G. Brucella abortus RB51: enhancing vaccine efficacy and developing multivalent vaccines. Vet Microbiol 2002, 90(December (1-4)):521-532.